Blocking the activation of CSF1R by CSF1R inhibitors such as Ki20227164 and GW2580165 or by antibodies such as anti-CSF1 antibodies166 and AFS98167 attenuates the progression of joint inflammation, bone erosion, and systemic bone erosion in animal models of arthritis. The gene discussed is CSF1R; the disease is arthritic joint disease.